Perioperative medicine & outcomes

Perioperative High‐Dose Steroid in Insulin‐Treated Patients With Diabetes Undergoing Fast‐Track Hip and Knee Arthroplasty: Impact on Length of Stay and Discharge Blood Glucose Levels

Acta Anaesthesiol ScandPublished Prospective observational study

Authors' conclusion

Glucose levels at discharge were slightly, but significantly higher in insulin-treated patients with diabetes receiving high-dose steroids compared to those receiving no/antiemetic doses and to non-insulin treated diabetes patients receiving high-dose steroids. However, there was no increase in fraction with LOS > 2 days or 30-day readmissions in the patients having high-dose steroids.

Study context

Population
Patients with insulin-treated diabetes undergoing fast-track hip or knee arthroplasty64% high-dose steroids
Participants
292 patients
Exposure
Perioperative high-dose steroid vs no/antiemetic steroid
Outcome
Discharge blood glucose concentration
Follow-up
Mean discharge
Methodological detailsmulticentre, eight Danish centres
  • Multicentre
  • Eight Danish centres

Main finding

As reported in the abstract

Discharge blood glucose

P = 0.011

Observational data: associations, not effects.

Secondary outcomes

OutcomeMean difference (mmol/L) (95% CI)P value
Discharge blood glucose, insulin-treated vs propensity-matched non-insulin-treated diabetes, all high-dose steroid (sensitivity analysis) · mean dischargePropensity-score matched cohort2.1 (1.3–2.8)P = < 0.001
OutcomeHigh-dose steroidNo/antiemetic steroidP value
LOS > 2 days10.1% (95% CI 6.6–15.3)15.2% (95% CI 9.6%–23.3%)P = 0.200
30-day readmission8% (95% CI 4.8–13)8.3% (95% CI 4.3–15.6)P = 0.923

Original publication

Perioperative High‐Dose Steroid in Insulin‐Treated Patients With Diabetes Undergoing Fast‐Track Hip and Knee Arthroplasty: Impact on Length of Stay and Discharge Blood Glucose Levels. Acta Anaesthesiol Scand. Published 22 July 2025. doi:10.1111/aas.70100

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.